BioSpace News Archive

Policy

Pfizer’s Read Predicts the End of Drug Rebates

Although no one really knows what President Trump will do to address high drug prices, Pfizer’s chief executive officer Ian Read said he believes it will crack down on drug rebates.

August 1, 2018
·
2 min read
·
Mark Terry
BioForest

VisCardia Announces First Implant of the VisONE® System for Treating Heart Failure

VisCardia Inc. announced today the first implant of the VisONE® implantable system for heart failure, and the commencement of its VisONE Heart Failure pilot study in Ukraine.

August 1, 2018
·
3 min read
Deals

TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million

TherapeuticsMD, Inc. (NASDAQ: TXMD) today announced the pricing of its previously announced $65 million underwritten public offering of common stock at a price to the public of $5.10 per share.

August 1, 2018
·
5 min read
Deals

BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

BioTime shareholders will receive one share of AgeX common stock for every 10 shares of BioTime common stock held

August 1, 2018
·
8 min read
Drug Development

CalciMedica Doses First Patients in Acute Pancreatitis Clinical Study

CalciMedica announced that the first patients in a Phase 2a clinical study for acute pancreatitis have been dosed with its proprietary calcium release-activated calcium (CRAC) channel inhibitor CM4620.

August 1, 2018
·
2 min read
Alkermes’ Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference

Alkermes plc announced that its corporate presentation will be webcast live at the 38th Annual Canaccord Genuity Growth Conference on Wednesday, Aug. 8, 2018 at 10:30 a.m. ET (3:30 p.m. BST) from Boston.

August 1, 2018
·
1 min read
Pharm Country

Yeast Still Grow - But Can’t Always Breed - When Their Sixteen Chromosomes Are Fused into Two

Study Provides Insight into How Sex Cells Fail, And How One Species Becomes Two

August 1, 2018
·
4 min read
BioMidwest

AtriCure Reports Second Quarter 2018 Financial Results

Worldwide revenue of $51.8 million – an increase of 14.5% year over year

August 1, 2018
·
11 min read
Business

STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018

STAAR Surgical Company reported financial results for the second quarter ended June 29, 2018.

August 1, 2018
·
15 min read
Business

Mirati Therapeutics Reports 2018 Second Quarter Financial Results

Mirati Therapeutics, Inc. reported financial results for the second quarter ended June 30, 2018.

August 1, 2018
·
11 min read